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The purpose of this study was to determine the prevalence and the most 
common risk factors of motor developmental delay in infants.
Materials & Methods
Following ethical approval, a study was carried out on the prevalence and 
risk factors of infants with motor developmental delay. The first stage was 
conducted through a cross-sectional study to determine the prevalence of 
motor developmental delay on 7500 infants and the second stage was an 
analytic case - control survey to identify the most common risk factors on 140 
infants, aged one month to three years with motor developmental delay. Data 
was collected using a demographic questionnaire, the Parents Evaluation of 
Developmental Status questionnaire, the Denver Developmental Screening Test 
II, a neurological assessment form, and the movement and tone assessment 
form. 
Results
The prevalence of motor developmental delay in 7500 infants was 18.7/1000. 
The most common risk factors in infants with motor developmental delay 
were prematurity (25.6%), low birth weight (19.2%), neonatal seizures (7.5%), 
hyaline membrane disease (6.7%), systemic infections of mothers during 
pregnancy (5.9%), severe neonatal hyperbilirubinemia (5%) in sequence. 
Motor developmental delay was significantly correlated with consanguinity of 
parents (p=0.001), prematurity (p=0.046), abnormal head circumference at birth 
(p=0.038), and low birth weight (p=0.026). 
Conclusion
The prevalence of motor developmental delay appears to be high and further 
studies should focus on different preventive strategies, controlling the most 
common risk factors and emphasizing on early detection and treatment of high 
risk infants.
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Introduction 
The documented prevalence of motor developmental delay (MDD) in the general 
population is reported to be more than 2-4/1000 (1, 2). In high risk infants, the 
prevalence of MDD is higher than that of the general population, being up to 73% 
in periventricular hemorrhagic infarction of prematurity (3). 
One of the most important risk factors for MDD is prematurity (3, 4). Bassan et al 
(2007), investigated neurodevelopmental outcome in survivors of periventricular 
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hemorrhagic infarction in 30 premature infants. The 
median adjusted age at evaluation was 30 months. They 
reported developmental delays involving gross motor, 
fine motor, visual, receptive and expressive language and 
cognitive domains in 73%, 59%, 46%, 38% and 50% of 
infants respectively. In the Ancel et al (2006) study, the 
prevalence of MDD was investigated in 1954 survivors 
at age of two years, in children born very preterm, 
according to gestational age; they reported a prevalence 
rate of 20% in infants born at 24 to 26 weeks of gestation 
and 4% in those born at 32 weeks. This study concluded 
that despite recent improvements in survival rates, MDD 
remains highly prevalent among very preterm children 
(4).
Mikkola et al (2005), investigated the neuro- 
developmental outcome at five years of age in 172 
extremely low birth weight infants (ELBW) born 
between 1996-1997, and demonstrated that the 
prevalence rate of MDD in infants with ELBW, born at 
<27 gestational weeks was 19% and that of those born 
at ≥27 gestational weeks was 9% (5).
In terms of other risk factors, in a study carried out by 
Wollack and Nichter (1996), the correlation of prevalence 
of MDD and Apgar score was investigated. Their results 
demonstrated that the prevalence of MDD significantly 
increased in children with birth asphyxia, and that in 
infants with an Apgar score of 0-3 at 1, 5, 15 and 20 
minutes of birth, the prevalence of MDD increased by 
1.5, 4.7, 16.7, 36 and 57.1%, respectively (6). 
Chen et al (2002), conducted a study to determine the 
underlying diseases and risk factors in children with 
different functional delays (cognitive, speech, motor, 
pervasive, global and non-specific developmental 
delays). The prevalence of MDD in children with motor 
delays was associated with risk of prematurity or low 
birth weight (LBW); while in children with global 
delays, it was associated with risks of genetic defects 
or congenital anomalies, suggesting suggesting that 
heterogeneous risk factors and related diseases are 
associated with different kinds of functional delay (7).
Furthermore, the prevalence of MDD significantly 
increases with a history of some risk factors such as 
kernicterus, multiple gestation, intracranial hemorrhage, 
malformations, severe bronchopulmonary dysplasia, 
and post hemorrhage hydrocephaly (6).
Obviously determining or highlighting the most 
important risk factors in any society is of great value 
since the most common risk factors differ in each 
society. Considering the increasing prevalence of 
MDD and that generally, developmental delays seem 
avoidable, every attempt should be made to prevent and 
control risk factors in order to reduce the prevalence of 
MDD. 
Although it is now broadly accepted that periodic 
developmental assessments are very crucial in early 
detection of MDD, unfortunately the developmental status 
of infants is not currently systemically and routinely 
assessed in Iranian health-care centers and pediatric 
clinics. Due to lack of resources, it seems difficult to 
perform developmental assessment for all infants in the 
country, thus periodic developmental assessments in high 
risk infants are strongly recommended. It is important to 
note that such infants usually have a history of one or 
more prenatal, perinatal or postnatal risk factors.
Considering the critical significance of the prevalence 
of MDD, addressing the most common risk factors in 
infants with MDD, and the limited research in Iran in 
this area, the present study was designed to determine 
the prevalence and the most common risk factors in 
Iranian infants with MDD.
Materials & Methods
Following ethical approval from the University of 
Social Welfare and Rehabilitation Sciences (USWR) 
Research Ethics Committee, a cross-sectional and an 
analytic (case-control type) study were carried out to 
determine the prevalence and the most common risk 
factors of MDD in Iranian children, aged between one 
month and three years. Data was collected using a 
demographic questionnaire, a neurological examination 
form and a movement and tone assessment form (8). 
The study was conducted at the Saba Developmental 
Disorders Center affiliated to the USWR, Tehran, 
Iran, between March 2004 and November 2005. Since 
generally Iranian infants refer to health-care centers 
for routine vaccination and periodical measurements 
of height, weight and head circumference, this setting 
was selected for the study. Inclusion criteria were: Age 
between one month to three years, living in the west, 
south and southwest of Tehran, willingness of parents 
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to take part and ability to read and write in Persian 
(Farsi); exclusion criteria were: Age over three years 
and lack of interest of the subjects’ parents. In infants ≤ 
2years, with a history of prematurity, the corrected age 
was used rather than the chronological age. 
A one-day workshop was held to train health-care 
workers on how to screen gross motor developmental 
delays by the Parents Evaluation of Developmental 
Status (PEDS) questionnaire and to refer infants 
suspected of MDD, to the Saba Center, the only referral 
center for evaluating such infants. 
Over a period of 20 months 7500 normal infants, aged 
one-month to three years, were referred to the west, 
south and southwest health-care centers of Tehran 
Health Network for monthly care and vaccination. 
About 85% of infants in the region are brought to 
health-care centers for different health-care purposes as 
services offered in these centers are provided free-of-
charge. These health centers provide coverage to almost 
50% of the rural and urban populations of Tehran city, 
since these areas are highly crowded and almost all 
infants in the region are brought to health-care centers 
for different health-care purposes. Hence all families, 
regardless of their income status, have equal access to 
the health-care services.
Following referral of infants through health-care 
workers, all parents were given written information 
sheets explaining the aims and plans of the research 
and were asked to sign a consent form if they agreed to 
take part; however if not, they would receive the usual 
services provided. 
Outcome Measures
Data was collected by a demographic questionnaire 
including age, sex, consanguinity of parents, type 
of delivery, number of siblings, family history, and 
prenatal, perinatal, and postnatal history. Although, 
the questionnaires were completed by parents, the 
information given by the parents was double checked with 
the children’s medical records, whenever necessary. 
Prenatal risk factors considered in this study were 
vaginal bleeding, systemic intrauterine bacterial 
and viral infections (such as rubella, chicken pox, 
cytomegalovirus and hepatitis B), mother’s non-
infectious diseases (such as toxemia of pregnancy, 
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diabetes mellitus, asthma, gastrointestinal diseases, 
significant anemia, thyroid diseases, uterine problems, 
and cardiac diseases), premature rupture of membrane, 
multiple gestations, and teratogens; perinatal risk 
factors taken into account were prematurity, prolonged 
labour, instrumental delivery, asphyxia, fetal distress, 
nuchal cord, and placenta previa; postnatal risk factors 
comprised of LBW, neonatal seizure, hyaline membrane 
disease (HMD), severe hyperbilirubinemia, sepsis and 
meningitis, congenital anomalies, neonatal pneumonia, 
metabolic disorders, congenital heart diseases, urinary 
tract infections, and severe anemia. 
During the study, 190 infants suspected of MDD and 
referred to the Saba Center, were assessed by a trained 
pediatrician. Gross motor development was assessed by 
the Denver Developmental Screening Test II (DDST II) 
and the neurological examination was performed on the 
basis of by a neurological examination form that consisted 
of items such as, primitive and postural reflexes, cranial 
nerve, sensory and cerebellar assessment. In addition, 
head circumference was measured and gait assessment 
was performed. The movement variability, muscle tone 
and antigravity movements were also assessed by the 
same pediatrician in eight standard positions (i.e. supine, 
side lying, prone, pull to sit, sitting, standing, horizontal 
suspension, and protective reaction). All infants with 
motor developmental levels, below 75% the normal 
level according to DDST II, or showed any abnormality 
in motor neurological examination, were considered 
infants with MDD, resulting in a diagnosis of MDD in 
140 infants. 
For the second part of the study, infants with MDD 
were considered as the case group while 140 normal 
matched (gender, age, socio-economical status) infants, 
referred to the west and southwest health-care centers for 
monthly care and vaccination, were randomly assigned 
as the control group. Nineteen infants were excluded 
from the case group since they either did not meet the 
inclusion criteria or their parents were not willing to 
participate in the study, and five participants dropped out 
from the control group, due to parental unwillingness to 
take participate. Hence this case-control study finally 
included the remaining 121 infants with MDD as the case 
group and 135 normal infants as the control group. The 
same demographic questionnaire was also completed by 
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parents of infants in control group.
Data analysis
Data was analyzed by the SPPS software, version 14, 
using the Chi-square, T test, and two-way analysis 
of variances (ANOVA) to analyze the data. Statistical 
significance was set at p=0.05. 
Results
In total, 140 infants were diagnosed with MDD, 
indicating a prevalence of MDD of 18.7/1000 (140 out 
of 7500) in this study.
Table (1) demonstrates the age distribution of children in 
the case and control groups. More than half of the infants 
in both groups were aged<1 year, as this is the age of 
children more commonly referred to health-care centers 
for monthly check ups; others are checked every two or 
three months, as the rate of referral at a higher age is 
low, compared to that of lower aged infants, for different 
reasons including parents’ willingness. 
Some demographic characteristics of samples are given 
in Table (2); there was no significant difference between 
the case and the control groups in terms of gender, birth 
type, presence of five children or more in the family, and 
a positive family history of MDD. However a statistically 
significant different was found between the case and the 
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control group, in terms of consanguinity of parents, birth 
weight, birth head circumference, and gestational age 
(Table 2).
The prevalence of prenatal risk factors is shown in 
histogram 1. There was a significant difference between 
the two groups in terms of intrauterine systemic bacterial 
infections (P= 0.00), while the rest were not significant 
(P>0.05). The most common prenatal risk factors in the 
case group were systemic bacterial infections (5.9%), 
hypertension (4.2%), diabetes mellitus (2.5%) and 
viral infections of mother during pregnancy (2.5%), 
respectively.
The prevalence of perinatal risk factors is shown 
in histogram 2. There was a statistically significant 
difference between the two groups only in prematurity 
(P= 0.046), whereas the rest were not significant 
(P>0.05); prematurity was also shown to be the most 
common perinatal risk factor in the cases (25.6%).
The prevalence of postnatal risk factors is shown in 
histogram 3. There was a significant difference between 
the two groups in terms of  LBW (P= 0.026), the rest 
not being significant (P>0.05). The most common 
postnatal risk factors in the cases were LBW (19.2%), 
neonatal seizure (7.5%), HMD (6.7%) and severe 
hyperbilirubinemia (5.0%). 
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0.001
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Discussion
In the current study the prevalence of MDD in infants 
and the most common risk factors for MDD such as 
prematurity, LBW, and hyperbilirubinemia were studied. 
According to the results of this study, the prevalence of 
MDD was 18.7/1000, a figure that appears to be higher 
than that already reported in current literature (1, 2). The 
higher prevalence rate in this study may be attributed 
to: 
a) the low to moderate socio-economic status of the 
population studied (9, 10 ); 
b) the transiently abnormal neurological findings in 
some cases (8, 11), indicating a longitudinal study 
is recommended. 
c) the coverage of health-care centers was not 100% for 
all infants born in those areas. 
The history of consanguinity in parents of children with 
MDD was significantly higher than those of the control 
group. Consanguinity in turn may contribute to MDD 
by expressing autosomal recessive disorders. Most 
inborn errors of metabolism (IEM), usually inherited 
as autosomal recessive, are considered to be one of the 
causes of MDD in infants. Consanguinity of parents 
causes IEM in infants, whereas they are easily preventable 
(12). Nasir et al (2004) investigated the probable causes 
of specific childhood disabilities in eastern Afghanistan 
and demonstrated that 46% of disabled children were 
born to parents who were first degree relatives (13). It 
seems that the difference between the findings of this 
study and those reported by Nasir et al (2004) might be 
due to the small sample size of the study conducted in 
Afghanistan. It also appears that the cultural differences 
of the population investigated might significantly 
influence the study results.
The large number of children in a family did not seem 
to be a risk factor in the current study, as there was no 
significant difference between the two groups; Although 
this result might be flawed due to the lack of families 
with more than 2-3 children in this study; this finding 
supports the results of previous studies, like that carried 
Fig 3: Prevalence of postnatal risk factors in case & control groups
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out by Kinsbourne and Graf (2000), in which no 
correlation was reported between the number of children 
and prevalence of MDD (14).
A history of developmental delay or MDD in the family 
and close relatives of the infant did not contribute to the 
occurrence of MDD. Stoll et al (2004) proposed that the 
presence of some genetic developmental diseases with 
specific inheritance (such as Mandelian autosomal and 
X-linked recessive) in the family, help in the diagnosis 
of the disease in infants (12).
Compared to the control group, prenatal risk factors were 
more prevalent in the case group although this difference 
was not statistically significant; the most common 
prenatal risk factor in the case group was systemic 
bacterial infection in the mother. In one study (15), 
intrauterine infection, maternal pyrexia, and the presence 
of thrombophilic disorders have been identified as major 
risk factors for subsequent MDD. The interactions of 
viral or bacterial infections during pregnancy in addition 
to normal or abnormal fetal cytokine responses as 
antenatal causes of the neuropathology of MDD are now 
areas of priority in future research. 
In some studies prenatal factors such as teratogenic 
drugs, radiation, vaginal bleeding and important 
diseases related to the mother, in particular diabetes and 
hypertension (pre-eclampsia and eclampsia), were also 
highlighted as major causes of high risk pregnancies 
resulting in the birth of high risk infants. However these 
factors can directly contribute to the occurrence of MDD 
by causing asphyxia and injuries to the developing brain 
(6). 
Due to the multiplicity of factors in this study, namely 
14 factors, future studies with larger samples are 
recommended to determine the effect of each factor on 
the prevalence of MDD.
In this study, the prevalence of perinatal risk factors was 
significantly higher in the case group. Prematurity and 
asphyxia have been the most common addressed risk 
factors in different studies. Generally different causes of 
prematurity can themselves be considered as potential 
threats for MDD; on the other hand, due to different 
premature organs, a premature infant is exposed to 
various problems such as HMD with the final outcome 
of decreased oxygen supply to the brain, which in turn 
contributes to MDD. An infant with a lower gestational 
age will have more problems (1, 14).
Stoelhorst (2003), investigated the effect of prematurity 
on developmental outcomes at the corrected age of 18 
and 24 months and concluded that, at 18 and 24- months 
corrected age, 40% of very prematurely born infants 
suffered from either delayed mental or psychomotor 
development, or both (16). In another study conducted 
on 200 children with MDD, in different rehabilitation 
centers in Tehran, prematurity was one of the most 
significant risk factors of MDD (17).
Postnatal risk factors are important in causing MDD 
in infants. The most common factors were LBW (less 
than 2500 gram), neonatal seizures, HMD and severe 
hyperbilirubinemia requiring exchange transfusion. 
Factors causing intrauterine growth retardation (IUGR) 
can also be influential in developing various problems 
such as hypoglycemia, asphyxia, polycytemia, 
hypothermia and dysmorphology in the neonatal period 
(14).
In the study carried out in Tehran on 200 cases with 
MDD (17), LBW and severe hyperbilirubinemia played 
a detrimental role in causing MDD. The combination of 
severe prematurity and IUGR are followed by serious 
developmental handicaps including MDD, blindness, 
deafness, and mental retardation, which predispose to 
physical and developmental delays (18).
Another study reported the association between 
fetal growth restriction and a rise in the risk of poor 
neurological outcomes. Increase in the risk of MDD 
in infants with>32 weeks’ gestation is one of the poor 
neurological outcomes mentioned in the Yanney and 
Marlow (19) study.
In general, according to the results of this study, the 
most common risk factors in infants with MDD were 
prematurity, LBW neonatal seizure, HMD, systemic 
bacterial infections in mothers during pregnancy, and 
severe hyperbilirubinemia, respectively. Therefore, 
further studies focusing on strategies in order to 
control and prevent such risk factors and on early 
detection and intervention in high risk infants are highly 
recommended.
Limitations
Some other risk factors such as congenital disorders 
were not included. Also due to limitations in assessing 
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sensory deficits (sight, and hearing) or communication 
deficiencies, these developmental delays were not 
included in the study. 
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